Be the first person to write a business review for Laboratory Corporation of America Holdings

Med BioGene Inc. (MBI: TSX Venture) is a life science company focused on the development and commercialization of genomic-based clinical laboratory diagnostic tests.The company develops gene expression assays (lab tests that examine organic samples on a molecular level) used to examine cancerous tumors. Its primary offering, LungExpress DX, is a late-stage assay candidate used to test lung cancer tumors in order to assist physicians in determining treatment options for their patients. The biotech firm's pipeline also contains similar methods for testing lymphoma and cardiovascular disease. Med BioGene filed for a US IPO in 2010, but fell short of funding and announced plans to review strategic alternatives later that year, including a possible sale or liquidation of the company.

MEDTOX is a full service laboratory, committed to providing clients with the services and solutions they need to run successful testing programs. For 25 years we have continually added new assays, support programs, new products and full laboratory divisions to meet the needs of our clients. MEDTOX services include.

MEDTOX Scientific, Inc. and its subsidiaries provide forensic and clinical laboratory services. The company also manufactures and distributes diagnostic and related devices. Its Laboratory Services segment offers drugs-of-abuse testing services. It also provides clinical and other laboratory services, including clinical toxicology, clinical testing for occupational health clinics, clinical testing for physician offices, pediatric lead testing, and analysis of heavy and trace metal. In addition, this segment offers services in the area of logistical support, data management, and program management; and pain management products.

Micro Identification Technologies Inc. ("MIT"), formerly Micro Imaging Technology is a development stage public company (OTCBB "MMTC"), objectives are to become a global leader in developing, supporting and marketing rapid systems and processes that detect and identify microbial organisms. MIT has developed and patented a technology for rapid microbe identification. The technology is a non-biological identification process that is extremely fast, easy to use and does not rely on conventional chemical or biological processing, fluorescent tags, gas chromatography or DNA analysis. The system measures scattered light intensity as individual microbes pass through a laser beam. The intensity pattern of the scattered light is a direct consequence of the size, shape and external and internal optical characteristics of the microbe. By measuring scattered light at specific angles, the system detects and differentiates objects the size of bacteria, protozoa, yeasts and molds.

Mid America Clinical Laboratories, LLC is a joint venture company owned by and in partnership with Community Hospital, St. Vincent Hospital, Quest Diagnostics and CoLab. We are the largest clinical laboratory in Indiana. We complete over 4.5 million tests per year. This test volume has doubled over the last 6 years.

Inviting Real Estate Agents, Job Placements Agents, Educational Institutes, Software Service Providers, Real Estate Builders, Marriage Bureaus, Travel Agents, Restaurant Owners, Health & Fitness Centers and other Local Businesses to Post a FREE Classified Advertisement on Cootera.com Classifieds Website.